Isabel P. Martins

Faculdade De Medicina Da Universidade De Lisboa & Hospital Universitario Sta Maria
Lisbon, Portugal

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 73 publications

Is achieving higher standards in real-world migraine care feasible with anti-CGRP monoclonal antibodies preventive therapies?: Insights from the EUREkA cohort.

Is achieving higher standards in real-world migraine care feasible with anti-CGRP monoclonal antibodies preventive therapies?: Insights from the EUREkA cohort.

Journal: Cephalalgia : an international journal of headache

Published: June 19, 2026

Beyond headache: Cognitive improvement in patients with migraine responding to anti-CGRP monoclonal antibodies or botulinum toxin.

Beyond headache: Cognitive improvement in patients with migraine responding to anti-CGRP monoclonal antibodies or botulinum toxin.

Journal: Cephalalgia : an international journal of headache

Published: June 15, 2026

Diagnostic tests and headache misdiagnoses in individuals with resistant and refractory migraine - data from the REFINE study.

Diagnostic tests and headache misdiagnoses in individuals with resistant and refractory migraine - data from the REFINE study.

Journal: Cephalalgia : an international journal of headache

Published: June 05, 2026

Long-Term Effectiveness and Persistence Factors of Anti-CGRP Monoclonal Antibodies in Migraine: 2-Year Results From the EUREkA Cohort.

Long-Term Effectiveness and Persistence Factors of Anti-CGRP Monoclonal Antibodies in Migraine: 2-Year Results From the EUREkA Cohort.

Journal: Neurology

Published: May 27, 2026

Evidence of stage-specific cognitive reserve effects on longitudinal cognition in amyotrophic lateral sclerosis.

Evidence of stage-specific cognitive reserve effects on longitudinal cognition in amyotrophic lateral sclerosis.

Journal: Journal of neuropsychology

Published: April 27, 2026

Cognitive Impairment Beyond Neurodegenerative Dementias: New Frontiers for Cognition in Neurological Disease.

Cognitive Impairment Beyond Neurodegenerative Dementias: New Frontiers for Cognition in Neurological Disease.

Journal: European journal of neurology

Published: April 15, 2026

Salience Network Dynamics Across Spontaneous Attacks, Interictal Rest and Interictal Pain Imagery in Menstrually Related Migraine.

Salience Network Dynamics Across Spontaneous Attacks, Interictal Rest and Interictal Pain Imagery in Menstrually Related Migraine.

Journal: Brain topography

Published: March 26, 2026

Therapeutic dissociation of CGRP-targeted treatments in migraine and complex regional pain syndrome.

Therapeutic dissociation of CGRP-targeted treatments in migraine and complex regional pain syndrome.

Journal: Cephalalgia : an international journal of headache

Published: March 23, 2026

Perception of facial trustworthiness in mild cognitive impairment.

Perception of facial trustworthiness in mild cognitive impairment.

Journal: Journal of Alzheimer's disease : JAD

Published: March 13, 2026

Long-Term Effectiveness and Persistence Factors of Anti-CGRP Monoclonal Antibodies in Migraine: 2-Year Results From the EUREkA Cohort.

Long-Term Effectiveness and Persistence Factors of Anti-CGRP Monoclonal Antibodies in Migraine: 2-Year Results From the EUREkA Cohort.

Journal: Neurology

Published: January 28, 2026

Can atogepant be a preventive treatment for cluster headache?-Insights from a case series.

Can atogepant be a preventive treatment for cluster headache?-Insights from a case series.

Journal: Headache

Published: June 29, 2025

Longitudinal assessment of migraine burden in resistant and refractory migraine - Data from the prospective REFINE study.

Longitudinal assessment of migraine burden in resistant and refractory migraine - Data from the prospective REFINE study.

Journal: The journal of headache and pain

Published: April 14, 2025

Showing 1-12 of 73

Last Updated: 09/26/2026